Literature DB >> 31173861

Proceedings of the 2018 annual meeting of the Fetal Alcohol Spectrum Disorders study group.

Anna Y Klintsova1, Derek A Hamilton2, Sandra M Mooney3, Christie L M Petrenko4.   

Abstract

The 2018 Fetal Alcohol Spectrum Disorders Study Group (FASDSG) meeting was entitled "Sex Differences and Vulnerability." The theme reflected the ongoing NIH initiative to address sex differences in both clinical and preclinical research. The first keynote speaker, Jill Becker, Ph.D., addressed sex differences in addiction in preclinical studies. The second keynote speaker, Meeyoung Min, Ph.D., discussed effects of gender on adolescent outcomes in poly-drug exposed children. The conference presented updates from three government agencies, a discussion panel of new data on FASD prevalence, and short presentations by junior and senior investigators showcasing late-breaking FASD research. The conference was capped by the presentation of Dr. Sarah Mattson, Ph.D., the recipient of the 2018 Henry Rosett award for career-long contributions to the field.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Annual study group meeting; Fetal Alcohol Spectrum Disorders; Proceedings

Mesh:

Year:  2019        PMID: 31173861      PMCID: PMC6891143          DOI: 10.1016/j.alcohol.2019.05.005

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  23 in total

Review 1.  A review of the neuroanatomical findings in children with fetal alcohol syndrome or prenatal exposure to alcohol.

Authors:  T M Roebuck; S N Mattson; E P Riley
Journal:  Alcohol Clin Exp Res       Date:  1998-04       Impact factor: 3.455

2.  Sex Differences in Early Postnatal Microglial Colonization of the Developing Rat Hippocampus Following a Single-Day Alcohol Exposure.

Authors:  M J Ruggiero; K E Boschen; T L Roth; A Y Klintsova
Journal:  J Neuroimmune Pharmacol       Date:  2017-12-22       Impact factor: 4.147

3.  Impaired alternation test performance in adult rats following prenatal alcohol exposure.

Authors:  B Zimmerberg; S Mattson; E P Riley
Journal:  Pharmacol Biochem Behav       Date:  1989-01       Impact factor: 3.533

Review 4.  A review of the effects of prenatal cocaine exposure among school-aged children.

Authors:  John P Ackerman; Tracy Riggins; Maureen M Black
Journal:  Pediatrics       Date:  2010-02-08       Impact factor: 7.124

5.  Sex differences and hormonal influences on acquisition of cocaine self-administration in rats.

Authors:  Lisa R Jackson; Terry E Robinson; Jill B Becker
Journal:  Neuropsychopharmacology       Date:  2006-01       Impact factor: 7.853

6.  Abnormalities of the corpus callosum in children prenatally exposed to alcohol.

Authors:  E P Riley; S N Mattson; E R Sowell; T L Jernigan; D F Sobel; K L Jones
Journal:  Alcohol Clin Exp Res       Date:  1995-10       Impact factor: 3.455

7.  Prenatal alcohol exposure and adolescent stress increase sensitivity to stress and gonadal hormone influences on cognition in adult female rats.

Authors:  Wendy L Comeau; Kristen Lee; Katie Anderson; Joanne Weinberg
Journal:  Physiol Behav       Date:  2015-02-21

8.  The effects of prenatal cocaine on language development at 10 years of age.

Authors:  Barbara A Lewis; Sonia Minnes; Elizabeth J Short; Paul Weishampel; Sudtida Satayathum; Meeyoung O Min; Suchitra Nelson; Lynn T Singer
Journal:  Neurotoxicol Teratol       Date:  2010-06-30       Impact factor: 3.763

9.  The association of prenatal cocaine exposure, externalizing behavior and adolescent substance use.

Authors:  Sonia Minnes; Meeyoung O Min; June-Yung Kim; Meredith W Francis; Adelaide Lang; Miaoping Wu; Lynn T Singer
Journal:  Drug Alcohol Depend       Date:  2017-03-24       Impact factor: 4.492

10.  Effects of a selectively bred novelty-seeking phenotype on the motivation to take cocaine in male and female rats.

Authors:  Jennifer A Cummings; Brooke A Gowl; Christel Westenbroek; Sarah M Clinton; Huda Akil; Jill B Becker
Journal:  Biol Sex Differ       Date:  2011-03-11       Impact factor: 5.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.